Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000554439 | SCV000645431 | pathogenic | Episodic kinesigenic dyskinesia | 2023-08-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 468617). This premature translational stop signal has been observed in individuals with paroxysmal kinesigenic dyskinesia, and infantile convulsions and paroxysmal choreoathetosis (PMID: 22464846, 22744660, 22752065, 22902309, 23363396, 28074849). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg217*) in the PRRT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRRT2 are known to be pathogenic (PMID: 22623405, 22744660). |
Baylor Genetics | RCV001332953 | SCV001525399 | pathogenic | Infantile convulsions and choreoathetosis | 2020-01-20 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV001545693 | SCV001765073 | pathogenic | not provided | 2022-06-29 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25340963, 28074849, 22464846, 22902309, 23551744, 22744660, 23363396, 24370076, 22752065, 29285950, 29655203, 32651081) |
MGZ Medical Genetics Center | RCV002289762 | SCV002581869 | pathogenic | Seizures, benign familial infantile, 2 | 2022-08-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001545693 | SCV004033474 | pathogenic | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | PRRT2: PVS1, PM2, PP1:Moderate, PS4:Moderate, PS3:Supporting |
Victorian Clinical Genetics Services, |
RCV004787889 | SCV005398960 | pathogenic | PRRT2-associated paroxysmal movement disorder | 2024-10-09 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.5, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with familial infantile convulsions with paroxysmal choreoathetosis (MIM#602066), episodic kinesigenic dyskinesia 1 (MIM#128200), benign familial infantile seizures 2 (MIM#605751) and self-limited familial and non-familial infantile seizures (MONDO#0100024). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance. Reduced penetrance has been reported for paroxysmal kinesigenic dyskinesia (PMID: 29334453). (I) 0115 - Variants in this gene are known to have variable expressivity. Variation in phenotype has been reported within and between families with the same pathogenic variant (PMID: 29334453). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v4) <0.001 for a dominant condition (3 heterozygotes, 0 homozygotes). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as pathogenic by multiple clinical laboratories in ClinVar, and has been observed in a family with PRRT2-related symptoms (PMID: 28074849). (SP) 1101 - Very strong and specific phenotype match for this individual. (SP) 1205 - This variant has been shown to be maternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
Genome Diagnostics Laboratory, |
RCV001545693 | SCV002034237 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001545693 | SCV002035216 | pathogenic | not provided | no assertion criteria provided | clinical testing |